Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found significantly higher P-Smad2 levels in both lesional and nonlesional skin of organ transplant recipients, suggesting elevated TGF-β signaling might contribute to their increased cancer susceptibility.

This article presents a practical tip to enhance the efficiency of follicular unit transplant hair restoration surgery, a procedure known for being effective yet time-consuming and laborious.

This article discusses Propecia® as the gold standard non-surgical medication for androgenetic alopecia following its five-year data release, but reports no new clinical findings.

This study explored the connections between Covid-19 and hair loss issues like telogen effluvium and alopecia areata, highlighting the virus's potential trigger effect and underscoring the importance of comprehensive post-Covid-19 treatment strategies that consider immune, psychological, and hair cycle factors.

In this study on tolerant rats, maternal and developmental toxicity from levo-alpha-acetyhnethadol hydrochloride were observed at all doses, without specific fetal toxicity or teratogenic effects.

This research found that the most common symptoms among COVID-19 patients at Afzalipour Hospital during the first peak were shortness of breath, dry cough, fever, myalgia, and fatigue, with fever more frequent in those under 50.

In this study, original natural organic cosmetics with a natural index of ≥ 90% and efficacy patents increased purchase intention and reduced promotional dependency in the US market.

This study examined 162 patients and found that those with both alopecia areata and atopic diseases showed higher cases of severe alopecia in children and a tendency for combined atopic diseases. Sensitization patterns were similar between alopecia areata patients and those with atopic diseases alone.

This article reviews studies on androgen hormone profiles in men with androgenetic alopecia and the effects of androgens and 5-alpha reductase on hair follicles, but provides no new findings.

Alopecia significantly harms emotional and social well-being.

This article identifies eight conditions that make patients unsuitable candidates for hair transplant surgery, emphasizing the importance of detailed consultations to recognize these factors, but reports no clinical results.

This article discusses the growing interest in hairline lowering surgery among patients and surgeons but reports no new clinical results or data.

This study found that patients with alopecia areata have significantly higher medication adherence than those with atopic dermatitis, potentially due to the stability and controllability of alopecia areata symptoms.

This review discusses the unmet supportive care needs of men and women experiencing chemotherapy-induced alopecia and reports no new results, urging healthcare providers to tailor interventions to individual patient needs.

This review discusses the potential use of cultured primary fetal cells from a single organ donation to produce therapeutic products, emphasizing the need for process consistency and safety verification, but reports no clinical results.

This study found that patients with alopecia areata had significantly lower serum levels of 25-hydroxy vitamin D compared to control subjects.

In this study, researchers reported that a new skin-responsive FU excision device consistently succeeded in all patients of African descent, showing a mean graft transection rate of less than 10%, with skin thickness and firmness identified as major factors affecting graft attrition rate.

This study in Mexican patients with alopecia areata found that body hair involvement was linked to disease progression, while treatment adherence was associated with both remission and progression.

This review summarizes expert opinions on the use of approved pharmacologic treatments alongside hair transplantation, highlighting their potential to enhance hair density and regrowth speed while reducing further hair loss, but reports no new clinical trial results.

In this study, researchers found that the JAK1/2 inhibitor ruxolitinib helped normalize tissue-specific autoimmunity in APECED patients by reducing inflammation and immune cell accumulation, but it was also linked to subclinical side effects like anemia and weight gain.

Hair loss negatively impacts quality of life, and psychological support can help.

This study employed multiple linear regressions to analyze hydantoin analogues and produced a model with strong predictive abilities for designing new androgen receptor modulators.

This case study reports a 15-year-old Burmese girl with telogen effluvium after receiving incorrect medication due to a pharmacy auto-complete error.

This study examined postmenopausal hyperandrogenism related to ovarian disease and found that specific biochemical markers can help differentiate between tumorous and non-tumorous cases, with a good level of sensitivity and specificity, supporting surgical intervention for resolution.

This study reported that 83.1% of patients with end-stage renal disease on hemodialysis experienced skin conditions, with xerosis affecting 63.6%, pruritis 36.4%, and notable occurrences of nail and oral anomalies, indicating a need for targeted dermatological management to improve patients' quality of life.

This review highlights similarities in the development of thymus and skin epidermis, reporting no new results; the authors emphasize shared molecular mechanisms despite different embryonic origins.

This study identified genetic variations associated with black and white wool color in Gangba sheep, enhancing understanding of wool color genetics and aiding selective breeding for specific wool colors in Tibetan sheep.

In this real-world study, low-level laser helmet therapy for androgenetic alopecia showed that male patients with specific scalp conditions may have better results after more than 180 uses or a year of treatment.

This study found that 93% of patients treated with adjuvant Paclitaxel and Trastuzumab for early-stage HER2-positive breast cancer experienced mild to moderate hair loss.